These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18339543)

  • 1. High-content analysis of cancer genome DNA alterations.
    Degenhardt YY; Wooster R; McCombie RW; Lucito R; Powers S
    Curr Opin Genet Dev; 2008 Feb; 18(1):68-72. PubMed ID: 18339543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Cell-Free DNA from 32,989 Advanced Cancers Reveals Novel Co-occurring Activating
    Rich TA; Reckamp KL; Chae YK; Doebele RC; Iams WT; Oh M; Raymond VM; Lanman RB; Riess JW; Stinchcombe TE; Subbiah V; Trevarthen DR; Fairclough S; Yen J; Gautschi O
    Clin Cancer Res; 2019 Oct; 25(19):5832-5842. PubMed ID: 31300450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apply innovative technologies to explore cancer genome.
    Shih IeM; Wang TL
    Curr Opin Oncol; 2005 Jan; 17(1):33-8. PubMed ID: 15608510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of mutations in DNA methylation modification genes on genome-wide methylation landscapes and downstream gene activations in pan-cancer.
    Lee CJ; Ahn H; Jeong D; Pak M; Moon JH; Kim S
    BMC Med Genomics; 2020 Feb; 13(Suppl 3):27. PubMed ID: 32093698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-resolution genomic and expression analyses of copy number alterations in breast tumors.
    Haverty PM; Fridlyand J; Li L; Getz G; Beroukhim R; Lohr S; Wu TD; Cavet G; Zhang Z; Chant J
    Genes Chromosomes Cancer; 2008 Jun; 47(6):530-42. PubMed ID: 18335499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted next generation sequencing of MLH1-deficient, MLH1 promoter hypermethylated, and BRAF/RAS-wild-type colorectal adenocarcinomas is effective in detecting tumors with actionable oncogenic gene fusions.
    Vaňková B; Vaněček T; Ptáková N; Hájková V; Dušek M; Michal M; Švajdler P; Daum O; Daumová M; Michal M; Mezencev R; Švajdler M
    Genes Chromosomes Cancer; 2020 Oct; 59(10):562-568. PubMed ID: 32427409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pan-cancer analysis of somatic mutations and epigenetic alterations in insulated neighbourhood boundaries.
    Pinoli P; Stamoulakatou E; Nguyen AP; Rodríguez Martínez M; Ceri S
    PLoS One; 2020; 15(1):e0227180. PubMed ID: 31945090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
    Pécuchet N; Legras A; Laurent-Puig P; Blons H
    Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep sequencing in cancer research.
    Yoshida K; Sanada M; Ogawa S
    Jpn J Clin Oncol; 2013 Feb; 43(2):110-5. PubMed ID: 23225907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of cancer genes by mutational profiling of tumor genomes.
    Benvenuti S; Arena S; Bardelli A
    FEBS Lett; 2005 Mar; 579(8):1884-90. PubMed ID: 15763568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-resolution melting analysis as a sensitive prescreening diagnostic tool to detect KRAS , BRAF , PIK3CA , and AKT1 mutations in formalin-fixed, paraffin-embedded tissues.
    Ney JT; Froehner S; Roesler A; Buettner R; Merkelbach-Bruse S
    Arch Pathol Lab Med; 2012 Sep; 136(9):983-92. PubMed ID: 22938585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer gene discovery in mouse and man.
    Mattison J; van der Weyden L; Hubbard T; Adams DJ
    Biochim Biophys Acta; 2009 Dec; 1796(2):140-61. PubMed ID: 19285540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The landscape and therapeutic relevance of cancer-associated transcript fusions.
    Yoshihara K; Wang Q; Torres-Garcia W; Zheng S; Vegesna R; Kim H; Verhaak RG
    Oncogene; 2015 Sep; 34(37):4845-54. PubMed ID: 25500544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Landscape of gene fusions in epithelial cancers: seq and ye shall find.
    Kumar-Sinha C; Kalyana-Sundaram S; Chinnaiyan AM
    Genome Med; 2015 Dec; 7():129. PubMed ID: 26684754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab.
    Demurtas L; Puzzoni M; Giampieri R; Ziranu P; Pusceddu V; Mandolesi A; Cremolini C; Masi G; Gelsomino F; Antoniotti C; Loretelli C; Meriggi F; Zaniboni A; Falcone A; Cascinu S; Scartozzi M
    Br J Cancer; 2017 Jul; 117(3):315-321. PubMed ID: 28632725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete genomic landscape of a recurring sporadic parathyroid carcinoma.
    Kasaian K; Wiseman SM; Thiessen N; Mungall KL; Corbett RD; Qian JQ; Nip KM; He A; Tse K; Chuah E; Varhol RJ; Pandoh P; McDonald H; Zeng T; Tam A; Schein J; Birol I; Mungall AJ; Moore RA; Zhao Y; Hirst M; Marra MA; Walker BA; Jones SJ
    J Pathol; 2013 Jul; 230(3):249-60. PubMed ID: 23616356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes.
    Durinck S; Stawiski EW; Pavía-Jiménez A; Modrusan Z; Kapur P; Jaiswal BS; Zhang N; Toffessi-Tcheuyap V; Nguyen TT; Pahuja KB; Chen YJ; Saleem S; Chaudhuri S; Heldens S; Jackson M; Peña-Llopis S; Guillory J; Toy K; Ha C; Harris CJ; Holloman E; Hill HM; Stinson J; Rivers CS; Janakiraman V; Wang W; Kinch LN; Grishin NV; Haverty PM; Chow B; Gehring JS; Reeder J; Pau G; Wu TD; Margulis V; Lotan Y; Sagalowsky A; Pedrosa I; de Sauvage FJ; Brugarolas J; Seshagiri S
    Nat Genet; 2015 Jan; 47(1):13-21. PubMed ID: 25401301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct oncogenes drive different genome and epigenome alterations in human mammary epithelial cells.
    Fonti C; Saumet A; Abi-Khalil A; Orsetti B; Cleroux E; Bender A; Dumas M; Schmitt E; Colinge J; Jacot W; Weber M; Sardet C; du Manoir S; Theillet C
    Int J Cancer; 2019 Sep; 145(5):1299-1311. PubMed ID: 31093963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of DNA methylation to mutational changes and transcriptional organization in fusion-positive and fusion-negative rhabdomyosarcoma.
    Sun W; Chatterjee B; Shern JF; Patidar R; Song Y; Wang Y; Walker RL; Pawel BR; Linardic CM; Houghton P; Hewitt SM; Edelman DC; Khan J; Meltzer PS; Barr FG
    Int J Cancer; 2019 Jun; 144(11):2707-2717. PubMed ID: 30565669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of genes involved in squamous cell carcinoma of the lung using synchronized data from DNA copy number and transcript expression profiling analysis.
    Lo KC; Stein LC; Panzarella JA; Cowell JK; Hawthorn L
    Lung Cancer; 2008 Mar; 59(3):315-31. PubMed ID: 18029052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.